Detalhe da pesquisa
1.
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohortâ.
J Hepatol
; 73(3): 505-515, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32298765
2.
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohortâ" [J Hepatol (2020) 505-515].
J Hepatol
; 78(5): 1085-1086, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36922251
3.
Corrigendum to: "Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort"â (J Hepatol [2020] 505-515).
J Hepatol
; 74(5): 1274-1275, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33678471
4.
TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease?
Gastroenterology
; 148(4): 679-84, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25639710
5.
TM6SF2 as a genetic risk factor for fibrosis.
Hepatology
; 62(4): 1321, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25502834
6.
A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?
Cancers (Basel)
; 13(6)2021 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33808740
7.
Reply to: HCC and liver disease risk in homozygous PNPLA3 p.I148M carriers approach monogenic inheritance.
J Hepatol
; 62(4): 982-3, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25559329
8.
Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans.
Aging (Albany NY)
; 9(1): 26-40, 2016 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27744419
9.
TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease.
Nat Commun
; 5: 4309, 2014 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24978903